Earnings Ahead

ILMN - Illumina

183.43 -8.45 -4.4

Illumina

Illumina

About

Profile

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ILMN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Illumina rises as Carl Icahn sees positives in CEO transition (update)
  • Illumina CEO Francis deSouza resigns
  • House Republicans seek information from FTC over Illumina's Grail deal
  • Illumina unit Grail in hot water over erroneous cancer results – FT
  • Illumina names Hologic CEO as chair, elects Edwards CFO to board
  • Illumina launches AI software to predict disease-causing genetic mutations
  • Illumina stock declines as shareholder voting results overdone - Evercore
  • Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises' weakness
  • Illumina chairman out, CEO survives, one Icahn nominee elected
  • Illumina director says company prepared if CEO, chairman tossed out - FT
  • Carl Icahn adds Illumina in Q1, cuts stakes in Herc, Newell Brands
  • Illumina board tells shareholders to ignore Carl Icahn's 'unfit associates'
  • Illumina wins partial victory in Icahn battle as proxy firm ISS backs CEO DeSouza
  • Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair
  • Carl Icahn urges Illumina to divest GRAIL as soon as possible
  • Illumina DNA sequencing devices could be vulnerable to hackers - FDA
  • Illumina unveils $100M annual cost cutting plan
  • Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M
  • Illumina under the spotlight as Q1 earnings approach
  • Carl Icahn further accuses Illumina board of 'obfuscation'

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 0.75 / 0.4562 1.2B / 1.13B Beat!
November 4, 2021 1.45 / 1.31 1.11B / 1.05B Beat!
August 5, 2021 1.87 / 1.36 1.13B / 1.02B Beat!
April 27, 2021 1.89 / 1.39 1.09B / 996.34M
February 11, 2021 1.22 / 1.11 953M / 903.91M Beat!
January 27, 2021 - / 1.42 - / 870.51M
October 29, 2020 1.02 / 0.813 794M / 715.83M Beat!
August 6, 2020 0.62 / 0.67 633M / 679.55M
April 30, 2020 1.64 / 1.26 859M / 853.91M Beat!
January 29, 2020 1.7 / 1.58 953M / 942.43M Beat!
October 24, 2019 1.93 / 1.4 907M / 870.9M Beat!
July 29, 2019 1.35 / 1.34 838M / 855.87M
April 25, 2019 1.6 / 1.34 846M / 834.28M Beat!
January 29, 2019 1.32 / 1.36 867M / 862.81M Beat!
October 23, 2018 1.52 / 1.26 853M / 828.24M Beat!
July 30, 2018 1.43 / 1.11 830M / 787.43M Beat!
April 24, 2018 1.45 / 1.02 782M / 744.3M Beat!
January 30, 2018 1.44 / 1.22 714.0M / 750.24M
October 24, 2017 1.11 / 0.99 662.0M / 692.84M
August 1, 2017 0.82 / 0.69 598.0M / 642.36M
April 25, 2017 0.64 / 0.64 598M / 590.75M Beat!
Date Price Open High Low Vol Change
Dec 2 127.55 129.01
129.5
127.43
1.1M -0.91%
Dec 1 128.72 129.88
132.15
128.27
1.9M -2.08%
Nov 28 131.45 130
131.48
129.27
966K 1.26%
Nov 26 129.81 128.82
130.57
128.45
2.1M 0.13%
Nov 25 129.64 125.76
130.47
125.5
1.6M 2.92%
 
Nov 24 125.96 123.75
127.88
123.33
2.3M 1.70%
Nov 21 123.85 119.26
125.41
118.97
2.4M 3.85%
Nov 20 119.26 122.65
126.94
117.86
2.4M -0.72%
Nov 19 120.12 121.64
122.38
119.85
1.9M -1.52%
Nov 18 121.97 118.33
122.27
117.5
1.5M 1.57%
Nov 17 120.08 119.15
122.79
118.59
1.6M -0.49%
Nov 14 120.67 117.32
121.5
117.1
1.1M 0.62%
Nov 13 119.93 120.21
123.65
119.04
1.6M -1.68%
Nov 12 121.98 122.79
124.84
121.84
1.3M -0.51%
Nov 11 122.6 122
125.5
122
2.4M 0.72%
Nov 10 121.72 123
124.5
120.73
1.1M -0.15%
Nov 7 121.9 120.21
122.08
119.36
1.1M 0.65%
Nov 6 121.11 122.48
124.04
118.5
2.1M -1.09%
Nov 5 122.44 121.5
126
120
2.9M 4.77%
Nov 4 116.86 117.9
121.25
116.21
2.3M -2.61%
Nov 3 119.99 121.13
124.07
116.26
3.1M -2.87%
Oct 31 123.54 106.91
123.93
106.12
6.8M 24.78%
Oct 30 99.01 94.39
99.39
94
3.0M 4.19%
Oct 29 95.03 97.22
98.55
94.91
1.3M -2.83%
Oct 28 97.8 100
100.18
97.64
1.0M -2.54%
Oct 27 100.35 101
101
98.86
1.3M 0.24%
Oct 24 100.11 101.44
101.93
100.06
949K 0.14%
Oct 23 99.97 97.23
100.24
97.07
1.3M 2.82%
Oct 22 97.23 98.39
99.54
95.82
1.7M -1.75%
Oct 21 98.96 100.41
102.31
98.5
1.3M -0.54%
Oct 20 99.5 95.61
100.94
95.61
1.8M 4.23%
Oct 17 95.46 95.2
96.8
94.81
1.2M -0.47%
Oct 16 95.91 94.05
98.7
93.5
2.2M 3.13%
Oct 15 93 90.71
95.61
90.1
2.8M 2.20%
Oct 14 91 92.75
93.8
88
2.6M -4.24%
Oct 13 95.03 95
96.43
93.59
775K 1.25%
Oct 10 93.86 96.49
96.49
91.65
1.6M -2.69%
Oct 9 96.45 97.63
98.7
96.34
911K -1.36%
Oct 8 97.78 96.66
98.39
95.71
1.2M 1.14%
Oct 7 96.68 101.36
101.95
96.5
1.4M -4.3%
Oct 6 101.02 102.16
102.68
100.56
1.3M -1.08%
Oct 3 102.12 100.35
102.84
99.49
1.7M 2.84%
Oct 2 99.3 103
103
98.52
1.9M -2.89%
Oct 1 102.26 94.97
102.35
94.97
2.3M 7.68%
Sep 30 94.97 91.64
95.44
91.3
2.1M 3.37%
Sep 29 91.87 92.26
92.5
90.62
1.5M 0.20%
Sep 26 91.69 92.29
93.03
91.41
2.2M -0.54%
Sep 25 92.19 93.51
94.19
91.36
2.0M -2.35%
Sep 24 94.41 99.5
99.77
93.92
1.7M -4.99%
Sep 23 99.37 101.33
102.91
98.87
1.2M -2.09%
Sep 22 101.49 102.75
102.75
101.07
952K -1.23%
Sep 19 102.75 102.79
103.94
101.69
3.6M -0.27%
Sep 18 103.03 102.31
103.78
101.6
1.1M 2.14%
Sep 17 100.87 101.75
104.22
99.5
1.7M -0.6%
Sep 16 101.48 100.79
102
98.86
1.5M 0.55%
Sep 15 100.92 95.31
101.01
95.2
1.8M 6.10%
Sep 12 95.12 99.51
99.51
95.12
1.5M -4.22%
Sep 11 99.31 95.69
99.56
95.63
1.7M 4%
Sep 10 95.49 98.08
98.8
94.83
1.2M -2.78%
Sep 9 98.22 98.42
98.48
97.02
784K 0%